Published January 1, 2015
| Version v1
Journal article
Open
Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity-27 month follow-up results from Turkey
- 1. Zeynep Kamil Gynocol & Pediat Educ & Res Hosp, Turkish Republ Minist Hlth, Istanbul, Turkey
- 2. Istanbul Univ, Affiliated Hosp, Surp Pirg Armenian Fdn Hosp, TR-34020 Istanbul, Turkey
Description
To study the efficacy of intravitreal bevacizumab (IVB) injection as a single treatment for retinopathy of prematurity (ROP).
Files
bib-f3b4bec4-57d2-4b79-892b-bcba3eea29c9.txt
Files
(301 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:fc9ee88e798de2fad4d38dca90dc775f
|
301 Bytes | Preview Download |